The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

UNAIDS statistics indicate that adolescent girls and young women (AGYW) aged 15-24 years continue to face a significant risk of HIV acquisition.

The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...

The Trump administration eliminated the CDC team that developed national guidelines for prescribing contraception safely for ...

President Trump’s budget proposal requests significant reductions to HIV prevention and surveillance programs. At the same ...

An infectious disease expert at the University of Minnesota uncovered a fake citation and errors just before they were presented Thursday to an influential federal panel considering safety concerns ...

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...

The CDC recently published revised recommendations urging routine HIV screening in healthcare settings for individuals age 13 to 64, unless they opt out.